全球動物健康夥伴條款與協議，2017-2026 年

讓我們利用基於 294 個真實案例的合約資料來了解動物保健產業的企業合作趨勢。

《2017-2026 年動物健康合作條款和協議》報告提供了有關 294 項與動物健康、技術和發展計劃相關的合作交易的全面資訊。

合作關係在動物保健產業中發揮著至關重要的作用，使公司能夠獲得創新成果、整合研發能力、獲得產品和技術權利、擴大生產能力並拓展商業性範圍。

這些合作關係涵蓋了從最初的研發合作到授權協議、製造、供應、分銷和商業化合約等各個方面。

本報告將這些活動匯總到一份文件中，使用戶能夠了解哪些公司正在合作、正在使用哪些交易結構、活動集中在哪些地區、正在披露哪些財務條款，以及每家公司在開發和商業化的每個階段是如何合作的。

本報告對動物保健領域的合作關係進行了廣泛的觀點，涵蓋動物保健產品、疫苗、診斷和相關動物保健技術，而不是專注於具體的交易類型。

本報告結合了全面的市場交易分析和金融基準、主要負責人資訊、詳細的交易記錄以及公開的合約文件。

本報告旨在為動物健康領域的業務發展、許可、公司策略、研發、商業策略、競爭情報分析以及參與合作的法律團隊提供參考。

了解動物健康領域合作關係的全貌。

本報告分析了2017年至2026年動物保健產業的交易趨勢，內容包括：

• 合作活動的年度趨勢
• 動物健康領域最活躍的交易商
• 按交易類型分類的合作關係趨勢
• 治療方法和疾病領域
• 技術類型
• 發展階段
• 根據已披露的交易金額，主要交易
• 可用的財務條款
• 動物健康領域夥伴關係策略的演變
• 本報告從市場角度概述了合作活動集中的領域，以及公司如何利用外部合作來開發和商業化觀點健康領域的創新。
• 比較各種動物健康合作模式
• 動物健康合作夥伴關係可以根據產品、技術、開發階段、市場機會以及參與各方的能力，以各種方式建構。

本報告探討了多種方法，其中包括以下幾種：

• 研究與開發夥伴關係
• 授權協議
• 發展夥伴關係
• 製造/供應合約
• 銷售合約
• 商業化夥伴關係
• 其他多因素交易
• 這樣就可以比較不同的合作路徑，而不是孤立地考慮每種合約類型。
• 動物健康交易的財務狀況基準分析

本報告詳細分析了動物保健產業合作交易中揭露的財務條款，包括以下內容：

• 交易總額
• 預付款
• 里程碑付款
• 版稅率
• 用戶可以透過查看這些基準背後的具體交易，深入了解所揭露的經濟狀況的背景。
• 這為內部基準測試、機會評估、交易準備和談判提供了一個現實的基準。
• 財務基準只有在結合類似交易的結構、發展階段、權利和情況進行解讀時，才能發揮其最大效用，而不僅將其視為平均值。本報告提供了建立這種背景所需的基礎交易資訊。
• 確定動物保健領域的關鍵交易商和潛在的未來合作夥伴。
• 該報告列出了動物保健領域最活躍的交易商，並提供了每家公司的交易歷史，使用戶能夠調查其過去的合作活動。

這有助於用戶識別以下內容：

• 公司積極尋求外部機會
• 有潛力的許可和合作研究夥伴
• 在動物健康特定領域反覆開展業務的組織
• 對特定技術表現出明顯興趣的公司
• 積極參與開發過程的交易商
• 潛在的商業化、銷售或開發合作夥伴
• 競爭對手採取類似的外部創新策略
• 過去的交易記錄可以提供有關一家公司參與外部夥伴關係意願的重要線索。
• 了解動物健康領域的合作活動集中在哪些方面。

本報告從以下幾個方面分析了動物保健貿易：

• 交易類型
• 治療或疾病領域
• 技術類型
• 發展階段
• 公司
• 這樣一來，使用者就可以確定合作活動頻繁的領域，並專注於與特定產品、技術或策略目標最相關的交易。
• 了解動物健康領域的合約結構

根據交易詳情和資訊披露，用戶可以調查以下方面：

• 授予和保留的權利
• 負責研發工作
• 許可範圍
• 獨家版權
• 地理和區域權利
• 智慧財產
• 發展和監管義務
• 製造和供應
• 負責分銷及銷售相關事宜
• 金錢補償
• 里程碑和版稅
• 管治
• 合約期限和終止條款
• 這些例子為思考如何在動物健康領域建立新的夥伴關係關係提供了有益的見解。
• 從實際合約文件中學習
• 本報告提供了部分動物健康相關交易的原始合約文件（如有公開版本）。

這些協議提供的資訊比公司新聞稿本身要詳細得多，使用戶能夠了解每個合作夥伴公司如何記錄以下內容：

• 權利範圍
• 智慧財產
• 發展義務
• 獨家代理權和目標區域
• 財務狀況
• 里程碑觸發條件
• 特許權使用費規定
• 製造和供應
• 商業化方面的責任
• 合約終止及後續權利
• 對於準備或談判動物健康交易的團隊來說，獲取實際的合約措辭可以提供寶貴的見解，了解類似的合作關係是如何實際建立的。
• 綜合動物健康交易目錄
• 本報告包含動物保健領域 294 個合作夥伴關係的綜合名錄，為識別相關的領先交易和公司提供了專門的資訊來源。

可使用以下標準對交易進行調查：

• 公司
• 發展階段
• 交易類型
• 治療或疾病領域
• 技術類型
• 合約揭露狀態
• 每筆交易都與其底層交易記錄相關聯，從而可以存取詳細的交易資訊和相關的合約文件（如有）。
• 誰該使用這份報告？
• 業務拓展與授權團隊
• 識別類似的動物保健交易、潛在合作夥伴及相關合約結構。
• 動物保健公司
• 我們對合作夥伴的活動進行基準測試，研究潛在的合作夥伴，並了解競爭對手如何取得外部產品和技術。
• 製藥和生物技術公司
• 我們將確定動物健康領域的合作活動，並找出正在積極開發和商業化動物健康及相關技術的組織。
• 尋求動物健康領域合作夥伴的公司
• 找出對相關產品、技術、疾病領域和研發階段表現出明確興趣的組織。
• 企業及研發策略團隊
• 我們追蹤各公司如何利用外部夥伴關係來注入創新並建立其動物保健產品組合。
• 銷售與行銷策略團隊
• 本研究調查了用於擴大動物保健產品市場滲透率的分銷、商業化和其他合作關係。
• 競爭與市場情報團隊
• 我們按公司、技術、疾病領域、階段和交易類型分析活動，以了解不斷變化的策略重點。
• 法律及交易團隊
• 為了協助交易準備和談判，我們將仔細檢視公開的合約和過去的交易案例。
• 我們將市場範圍內的動物健康資訊轉化為公司特有的洞察。
• 符合資格的客戶除了收到報告外，還將收到 Current Partnering 提供的客製化合作夥伴簡報。
• 本簡報將把有關動物保健產業交易的基本資訊應用於您的特定產品、技術、投資組合或合作目標。
• 如有需要，我們可以提供相關的類似交易、潛在的未來合作夥伴、競爭對手的活動、交易結構、發展階段分析、財務基準、忠誠度分析、合約見解以及其他專門為您情況選擇的資訊。
• 請索取樣本或聯絡 Current Partnering 討論本報告的內容以及我們是否可以為貴公司提供客製化分析。

目錄

執行摘要

第1章 引言

第2章：動物保健領域交易趨勢

• 動物健康領域的長期合作關係趨勢
• 動物保健領域最活躍的交易實體
• 動物健康領域的合作夥伴關係（按交易類型分類）
• 按治療領域分類的動物健康領域合作夥伴關係
• 按技術類型分類的動物健康領域合作夥伴關係
• 動物健康領域合作的條款與條件
  • 動物健康領域合作計畫的總合約價值
  • 動物健康交易中的預付款
  • 動物健康交易中的里程碑付款
  • 動物健康忠誠度

第3章：典型的動物健康交易

• 按交易量排名的前幾大動物保健交易

第4章：動物保健領域最活躍的交易商

• 動物健康領域最活躍的交易商
• 動物健康領域最活躍的合作夥伴公司簡介

第5章：動物保健合約交易指南

• 動物健康合約交易指南

第6章：按技術分類的動物保健產業交易趨勢

附錄

• 附錄 1 - 按公司名稱（A-Z）列出的動物保健交易清單
• 附錄 2 - 依發展階段分類的動物保健貿易
• 附錄 3 - 按交易類型分類的動物健康交易
• 附錄 4 - 按治療領域分類的動物健康交易
• 附錄5 - 交易類型的定義
• 附錄 6 - 參考文獻
• 關於生物製藥研究
• Current Partnering
• Current Agreements
• 理想合作夥伴近期報告標題

Animal Health Partnering Terms and Agreements 2017-2026

Understand how companies partner across the animal health industry using intelligence from 294 real-world agreements.

Animal Health Partnering Terms and Agreements 2017-2026 provides comprehensive intelligence on 294 partnering deals involving animal health products, technologies and development programs.

Partnerships play an important role throughout the animal health industry, enabling companies to access innovation, combine research and development capabilities, secure rights to products and technologies, expand manufacturing capacity and extend commercial reach.

These relationships can take many forms, from early research and development collaborations through to licensing, manufacturing, supply, distribution and commercialization agreements.

The report brings this activity together in one resource, enabling users to understand who is partnering, which deal structures are being used, where activity is concentrated, what financial terms have been disclosed and how companies are working together across development and commercialization.

Rather than focusing on a single transaction type, the report provides a broad view of animal health partnering across veterinary medicines, vaccines, diagnostics and related animal health technologies.

It combines market-wide deal analysis with financial benchmarking, leading dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.

The report is designed for business development, licensing, corporate strategy, R&D, commercial strategy, competitive intelligence and legal teams involved in animal health partnering.

Understand the animal health partnering landscape

The report analyzes animal health dealmaking from 2017 to 2026, including:

• Trends in partnering activity by year
• Most active animal health dealmakers
• Partnering activity by deal type
• Therapy and disease area
• Technology type
• Stage of development
• Leading deals by disclosed value
• Financial terms where available
• How animal health partnering strategies are evolving
• This provides a market-wide view of where partnering activity is concentrated and how companies are using external relationships to develop and commercialize animal health innovation.
• Compare different animal health partnership models
• Animal health partnerships can be structured in many different ways according to the product, technology, development stage, market opportunity and capabilities of the parties.

The report enables users to investigate multiple approaches, including:

• Research and development collaborations
• Licensing agreements
• Development partnerships
• Manufacturing and supply arrangements
• Distribution agreements
• Commercialization partnerships
• Other multi-component transactions
• This makes it possible to compare alternative partnering routes rather than considering individual agreement types in isolation.
• Benchmark animal health deal financials

The report provides dedicated analysis of disclosed financial terms across animal health partnering transactions, including:

• Headline deal values
• Upfront payments
• Milestone payments
• Royalty rates
• Users can investigate the individual transactions behind these benchmarks to understand the circumstances surrounding the disclosed economics.
• This provides real-world reference points for internal benchmarking, opportunity assessment, deal preparation and negotiation.
• Financial benchmarks are most useful when interpreted alongside the structure, development stage, rights and circumstances of comparable transactions rather than as standalone averages, and the report provides the underlying deal intelligence needed to establish that context.
• Identify leading animal health dealmakers and prospective partners
• The report identifies the most active animal health dealmakers and provides company-level transaction histories that enable users to investigate their previous partnering activity.

This can help users identify:

• Companies actively seeking external opportunities
• Prospective licensing and collaboration partners
• Organizations repeatedly active in particular animal health areas
• Companies with demonstrated interest in specific technologies
• Dealmakers active at relevant stages of development
• Potential commercial, distribution or development partners
• Competitors pursuing similar external innovation strategies
• Previous transaction activity provides useful evidence of where individual companies have demonstrated an appetite for external partnering.
• Understand where animal health partnering activity is concentrated

The report analyzes animal health transactions by:

• Deal type
• Therapy or disease area
• Technology type
• Stage of development
• Company
• This enables users to identify areas attracting partnering activity and focus on the subset of transactions most relevant to a particular product, technology or strategic objective.
• Understand how animal health agreements are structured

Depending on the transaction and available disclosure, users can investigate areas including:

• Rights granted and retained
• Research and development responsibilities
• Licensing scope
• Exclusivity
• Geographic and territorial rights
• Intellectual property
• Development and regulatory obligations
• Manufacturing and supply
• Distribution and commercialization responsibilities
• Financial consideration
• Milestones and royalties
• Governance
• Term and termination provisions
• These real-world examples provide useful reference points when considering how a new animal health partnership might be structured.
• Learn from real-world contract documents
• Where publicly available, the report provides access to underlying contract documents for selected animal health transactions.

These agreements can provide substantially more detail than company announcements alone, enabling users to examine how partners have documented matters including:

• Scope of rights
• Intellectual property
• Development obligations
• Exclusivity and territory
• Financial terms
• Milestone triggers
• Royalty provisions
• Manufacturing and supply
• Commercialization responsibilities
• Termination and continuing rights
• For teams preparing or negotiating an animal health transaction, access to real agreement language provides valuable insight into how comparable partnerships have been structured in practice.
• Comprehensive animal health deal directory
• The report includes a comprehensive directory of 294 animal health partnering deals, providing a focused resource for identifying relevant precedent transactions and companies.

Deals can be investigated by:

• Company
• Stage of development
• Deal type
• Therapy or disease area
• Technology type
• Contract availability
• Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
• Who should use this report?
• Business Development and Licensing teams
• Identify comparable animal health transactions, prospective partners and relevant agreement structures.
• Animal Health Companies
• Benchmark partnering activity, investigate potential partners and understand how peer companies are accessing external products and technologies.
• Pharmaceutical and Biotechnology Companies
• Understand partnering activity in animal health and identify organizations actively developing and commercializing veterinary products and technologies.
• Companies Seeking Animal Health Partners
• Identify organizations with demonstrated interest in relevant products, technologies, disease areas and stages of development.
• Corporate and R&D Strategy teams
• Track how companies are using external partnerships to access innovation and build animal health portfolios.
• Commercial and Market Strategy teams
• Investigate distribution, commercialization and other partnerships used to extend the reach of animal health products.
• Competitive and Market Intelligence teams
• Analyze activity by company, technology, disease area, stage and transaction type to understand evolving strategic priorities.
• Legal and Transaction teams
• Review publicly available agreements and precedent structures to support transaction preparation and negotiation.
• Turn market-wide animal health intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing applies the underlying animal health deal intelligence to the customer's own products, technologies, portfolio or partnering objectives.
• Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, deal structures, development-stage analysis, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in animal health dealmaking

• 2.1. Introduction
• 2.2. Animal health partnering over the years
• 2.3. Most active animal health dealmakers
• 2.4. Animal health partnering by deal type
• 2.5. Animal health partnering by therapy area
• 2.6. Animal health partnering by technology type
• 2.7. Deal terms for animal health partnering
  • 2.7.1 Animal health partnering headline values
  • 2.7.2 Animal health deal upfront payments
  • 2.7.3 Animal health deal milestone payments
  • 2.7.4 Animal health royalty rates

Chapter 3 - Leading animal health deals

• 3.1. Introduction
• 3.2. Top animal health deals by value

Chapter 4 - Most active animal health dealmakers

• 4.1. Introduction
• 4.2. Most active animal health dealmakers
• 4.3. Most active animal health partnering company profiles

Chapter 5 - Animal health contracts dealmaking directory

• 5.1. Introduction
• 5.2. Animal health contracts dealmaking directory

Chapter 6 - Animal health dealmaking by technology type

Appendices

• Appendix 1 - Animal health deals by company A-Z
• Appendix 2 - Animal health deals by stage of development
• Appendix 3 - Animal health deals by deal type
• Appendix 4 - Animal health deals by therapy area
• Appendix 5 - Deal type definitions
• Appendix 6 - Further reading
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Animal health partnering since 2017
• Figure 2: Active animal health dealmaking activity- 2017 to 2024
• Figure 3: Animal health partnering by deal type since 2017
• Figure 4: Animal health partnering by disease type since 2017
• Figure 5: Animal health partnering by technology type since 2017
• Figure 6: Animal health deals with a headline value
• Figure 7: Animal health deals with an upfront value
• Figure 8: Animal health deals with a milestone value
• Figure 9: Animal health deals with a royalty rate value
• Figure 10: Top animal health deals by value since 2017
• Figure 11: Most active animal health dealmakers 2017 to 2024